Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
ATRC
ATRC
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ATRC News
AtriCure Shares Plunge After JPMorgan Downgrade
4d ago
seekingalpha
Elekta EKTAY's Evo CT-Linac Receives FDA Clearance, Enhancing Personalized Radiation Therapy
Jan 19 2026
NASDAQ.COM
DexCom Reports Q4 2025 Revenue of $1.26 Billion, Up 13%
Jan 16 2026
NASDAQ.COM
VentriPoint Diagnostics Secures $1 Million Funding to Propel AI Medical Imaging Growth
Jan 16 2026
Globenewswire
AtriCure Inc (ATRC) Releases 2025 Product Pipeline Analysis Report
Jan 01 2026
Businesswire
AtriCure (ATRC) Sees a 6.32% Increase Over the Past Week: Key Information to Consider
Dec 19 2025
NASDAQ.COM
Wall Street Analysts Predict AtriCure (ATRC) May Surge 36.3%: Here's How to Invest
Nov 25 2025
NASDAQ.COM
Key Metrics Insights on AtriCure's (ATRC) Revised Q3 Earnings
Nov 06 2025
NASDAQ.COM
Fascinating ATRC Put and Call Options Set for December 19th
Oct 28 2025
NASDAQ.COM
Analysts Predict FHLC Will Hit $78
Oct 23 2025
NASDAQ.COM
AtriCure to Take Part in the 2025 Wells Fargo Healthcare Conference
Aug 20 2025
Newsfilter
Needham Maintains Buy on AtriCure, Raises Price Target to $45
Jul 30 2025
Benzinga
Why LendingClub Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket
Jul 30 2025
Benzinga
AtriCure Completes Enrollment in LeAAPS Clinical Trial for Stroke Prevention
Jul 15 2025
Newsfilter
Interesting ATRC Put And Call Options For August 15th
Jun 30 2025
NASDAQ.COM
Visa To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday
Apr 30 2025
Benzinga
Show More News
